Results 171 to 180 of about 235,541 (221)

Dislocation of Dexamethasone Intravitreous Implant

Archives of Ophthalmology, 2012
tiviral drugs. Eur J Ophthalmol. 2001;11(2):200-202. 22. Yang CM, Wang WW, Lin CP. Progressive outer retinal necrosis syndrome as an early manifestation of human immunodeficiency virus infection. J Formos Med Assoc. 1999;98(2):141-144. 23. Perez-Blazquez E, Traspas R, Mendez Marin I, Montero M.
Voykov, Bogomil Nikolov, Bartz-Schmidt, Karl U.   +1 more
openaire   +3 more sources

Intravitreal Injection of Ozurdex® Implant in Patients With Persistent Diabetic Macular Edema, With Six-Month Follow-Up [PDF]

Ophthalmology and Eye Diseases, 2016
Aim To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). Methods A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected with ...
Fernanda Pacella, Elena Pacella, Tommaso Lenzi   +2 more
exaly   +2 more sources

Reverse engineering the Ozurdex dexamethasone intravitreal implant

International Journal of Pharmaceutics, 2023
Ozurdex is a biodegradable implant formulated for sustained-release delivery of the corticosteroid dexamethasone to the posterior segment of the eye. The small, rod-shaped implant is administered directly to the vitreous using a dedicated applicator, and releases drug for up to 6 months after administration.
Mark A, Costello, Joseph, Liu, Yan, Wang, Bin, Qin, Xiaoming, Xu, Qi, Li, Nathaniel A, Lynd, Feng, Zhang   +7 more
openaire   +2 more sources

Dexamethasone intravitreal implant in serpiginous choroiditis

British Journal of Ophthalmology, 2016
To assess the efficacy and safety of dexamethasone (DEX) intravitreal implant in patients with active serpiginous choroiditis (SC) already receiving maximal tolerated systemic immunosuppressive therapy.In this retrospective longitudinal study we evaluated patients receiving 0.7 mg DEX intravitreal implant for active SC despite maximal systemic ...
Miserocchi, Elisabetta, Berchicci, Luigi, Iuliano, Lorenzo, Modorati, Giulio, Bandello, Francesco   +4 more
openaire   +2 more sources

Safety of 6000 intravitreal dexamethasone implants

British Journal of Ophthalmology, 2019
PurposeTo evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.MethodsRetrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 ...
Masarwa, Dua, Novais, Eduardo, Giancipoli, Ermete, Cagini, Carlo, Bandello, Francesco, Dolz Marco, Rosa, Kumar, S., Sarvaiya, Chintan, Veritti, Daniele, Sarvaiya, Chintan, Veritti, Daniele, Zur, Dinah, Masarwa, Dua, Zur, Dinah, Patyal, S., Kumar, S., Masarwa, Dua, Zur, Dinah, Veritti, Daniele, Sarvaiya, Chintan, Bernal-Morales, Carolina, Cebeci, Zafer, Chaikitmongkol, Voraporn, Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha, Patyal, S., Kumar, S., Dolz Marco, Rosa, Gallego-Pinazo, Roberto, Shenoy, Prateek, Gabrielle, Pierre-Henry, D'Anna-Mardero, Oriana, Rajesh, Bindu, Rassu, Nicolo, Asencio-Duran, Monica, Maia, Mauricio, Cavalleri, Michele, Rasheed, Mohammed Abdul, Nagpal, Manish, Casella, Marcelo, Lupidi, Marco, Avila, Marcos, Berrocal, Maria, Cavalleri, Michele, Maia, Mauricio, Iglicki, Matias, Berrocal, Maria, Avila, Marcos, Iglicki, Matias, Lupidi, Marco, Casella, Marcelo, Rasheed, Mohammed Abdul, Asencio-Duran, Monica, Rassu, Nicolo, Ayhan, Ziya, Cebeci, Zafer, Al-khersan, Hasenin, Wong, J. S., Chaikitmongkol, Voraporn, Nagpal, Manish, Okada, Mali, Wu, Lihteh, Raji, K., Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha, Patyal, S., Novais, Eduardo, Giancipoli, Ermete, Raji, K., Wu, Lihteh, Okada, Mali, Bandello, Francesco, D'Anna-Mardero, Oriana, Gabrielle, Pierre-Henry, Shenoy, Prateek, Gallego-Pinazo, Roberto, Wong, J. S., Al-Khersan, Hasenin, Sharma, Ashish, Sala-Puigdollers, Anna, Maiti, Aniruddha, Maia, Andre, AYHAN, ZİYA, SAATCİ, ALİ OSMAN, Dolz Marco, Rosa, Gallego-Pinazo, Roberto, Shenoy, Prateek, Gabrielle, Pierre-Henry, D'Anna-Mardero, Oriana, Marashi, Ameen, Rassu, Nicolo, Asencio-Duran, Monica, Rasheed, Mohammed Abdul, Cavalleri, Michele, Maia, Mauricio, Iglicki, Matias, Berrocal, Maria, Avila, Marcos, Lupidi, Marco, Casella, Marcelo, Nagpal, Manish, Bernal-Morales, Carolina, Sen, Alok C., Banker, Alay, Mansour, Ahmad, Goud, Abhilash, Singh, A., Gupta, A., Chhablani, Jay, Kodjikian, Laurent, Arevalo, J. Fernando, Lanzetta, Paolo, Okada, Mali, Farah, Michel Eid, Querques, Giuseppe, Udaondo Mirete, Patricia, Mishra, Sanjay Kumar, Wu, Lihteh, Sarao, Valentina, Rodriguez-Valdes, Patricio J., Sahoo, Niroj Kumar, Busch, Catharina, Fung, Adrian T., Zarranz-Ventura, Javier, Raji, K., Wong, J. S., Al-khersan, Hasenin, Bandello, Francesco, Giancipoli, Ermete, Novais, Eduardo, Bernal-Morales, Carolina, Ayhan, Ziya, Cebeci, Zafer, Chaikitmongkol, Voraporn, Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha   +144 more
openaire   +7 more sources

INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY

RETINAL Cases & Brief Reports, 2017
Purpose: Birdshot chorioretinopathy is a rare form of posterior uveitis. This article reports a case series of patients with HLA-A29+ birdshot chorioretinopathy managed with intravitreal dexamethasone implants.
James, Walsh, Ashvini K, Reddy
openaire   +2 more sources

Dexamethasone Intravitreal Implant (Ozurdex)

Canadian Journal of Health Technologies, 2023
CADTH recommends that Ozurdex not be reimbursed by public drug plans for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor (VEGF) therapy. Evidence from 1 clinical trial and 2 observational studies was insufficient to demonstrate
openaire   +1 more source

Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits

Biomaterials, 2001
To study the biocompatibility and the biodegradation rate in vivo of new intravitreal implants made with three different hyaluronic acid esters: Hyaff7, Hyaff11 and Hyaff11p75 (100% ethyl ester, 100 and 75% benzyl esters, respectively), the plugs were implanted through a sclerotomy at 3.5 mm from the limbus of rabbit eyes.
AVITABILE, Teresio, MARANO F, CASTIGLIONE F, BUCOLO, CLAUDIO, CRO M, AMBROSIO L, FERRATO C, REIBALDI A.   +7 more
openaire   +5 more sources